Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Blood Neoplasia|June 2, 2025
Prognostic impact of RDI of vincristine in patients with DLBCL receiving R-CHOP: a supplementary analysis of JCOG0601Takahiro Nakashima, Tomotaka Suzuki, Ryunosuke Machida, et al.
Cancer Science|December 20, 2025
Impact of Achieving Progression-Free Survival 24 on Subsequent Overall Survival in Diffuse Large B-Cell Lymphoma PatientsAyumi Fujimoto, Wataru Munakata, Gakuto Ogawa, et al.
Japanese Journal of Clinical Oncology|July 18, 2024
High cost of chemotherapy for gynecologic malignanciesNobutaka Takahashi, Toshiyuki Seki, Keita Sasaki, et al.
BMC Cancer|November 6, 2023
Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE)Tomoya Yokota, Sadamoto Zenda, Takeshi Kodaira, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 1, 2020
Impact of postoperative complications on survival outcomes in patients with gastric cancer: exploratory analysis of a randomized controlled JCOG1001 trialMasanori Tokunaga, Yukinori Kurokawa, Ryunosuke Machida, et al.
Lung Cancer (Amsterdam, Netherlands)|April 16, 2024
Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trialSeiji Niho, Jun Sato, Miyako Satouchi, et al.
Japanese Journal of Clinical Oncology|August 23, 2024
Status of incremental costs of first-line treatment recommended in Japanese clinical guidelines for metastatic breast cancer patientsTsuguo Iwatani, Keita Sasaki, Ryunosuke Machida, et al.
Japanese Journal of Clinical Oncology|August 19, 2024
High-cost treatments for advanced lung cancer in Japan (Lung Cancer Study Group of the Japan Clinical Oncology Group)Kageaki Watanabe, Keita Sasaki, Ryunosuke Machida, et al.
Japanese Journal of Clinical Oncology|October 6, 2023
A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904)Keita Sasaki, Motoo Nomura, Ken Kato, et al.
BMC Cancer|August 9, 2022
A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trialYohei Chiba, Kazuki Sudo, Yuki Kojima, et al.
Pageof 8